Newer treatment options for skin and soft tissue infections (Q35838370)

10 August 2017

1 reference

title

Newer treatment options for skin and soft tissue infections (English)

1 reference

10 August 2017

Murugan Raghavan

1

1 reference

10 August 2017

Peter K Linden

series ordinal

2

1 reference

10 August 2017

language of work or name

1 reference

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

64

1 reference

10 August 2017

15

1 reference

10 August 2017

1621-1642

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464150-00002

10 August 2017

0 references

cites work

A practical guide to the treatment of complicated skin and soft tissue infections

1 reference

12 December 2020

Linezolid and reversible myelosuppression

1 reference

12 December 2020

Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.

1 reference

12 December 2020

In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers

1 reference

12 December 2020

Penetration of levofloxacin into skin tissue after oral administration of multiple 750 mg once-daily doses

1 reference

12 December 2020

Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an International Surveillance Programme. SENTRY Participants Group.

1 reference

12 December 2020

The streptogramin antibiotics: update on their mechanism of action.

1 reference

12 December 2020

Gatifloxacin: a review of its use in the management of bacterial infections

1 reference

12 December 2020

Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium

1 reference

12 December 2020

Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen

1 reference

12 December 2020

Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium

1 reference

12 December 2020

High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998-1999.

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991

1 reference

12 December 2020

Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383

1 reference

12 December 2020

Linezolid-induced neuropathy

1 reference

12 December 2020

Daptomycin. Cidecin, Dapcin, LY 146032

1 reference

12 December 2020

Linezolid-associated toxic optic neuropathy: a report of 2 cases

1 reference

12 December 2020

Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients

1 reference

12 December 2020

Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.

1 reference

12 December 2020

Successful administration of quinupristin/dalfopristin in the outpatient setting

1 reference

12 December 2020

Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000)

1 reference

12 December 2020

Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens

1 reference

12 December 2020

Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.

1 reference

12 December 2020

The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group

1 reference

12 December 2020

In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

12 December 2020

Tooth discoloration after treatment with linezolid

1 reference

12 December 2020

In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria

1 reference

12 December 2020

Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community.

1 reference

12 December 2020

Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study

1 reference

12 December 2020

Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections

1 reference

12 December 2020

1 reference

12 December 2020

Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia

1 reference

12 December 2020

Pharmacokinetics of linezolid in subjects with renal dysfunction

1 reference

12 December 2020

Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.

1 reference

12 December 2020

Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group.

1 reference

12 December 2020

Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections

1 reference

12 December 2020

Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998.

1 reference

12 December 2020

Teicoplanin Chemistry and Microbiology

1 reference

12 December 2020

In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis

1 reference

12 December 2020

Review of qoinolones in the treatment of infections of the skin and skin structure

1 reference

12 December 2020

Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates

1 reference

12 December 2020

Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus

1 reference

12 December 2020

Vancomycin-resistant enterococci: the clinical effect of a common nosocomial pathogen.

1 reference

12 December 2020

In vitro activities of LY333328 and comparative agents against nosocomial gram-positive pathogens collected in a 1997 global surveillance study

1 reference

12 December 2020

A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections

1 reference

12 December 2020

Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit

1 reference

12 December 2020

Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial

1 reference

12 December 2020

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

1 reference

12 December 2020

Optimal treatment of complicated skin and skin structure infections

1 reference

12 December 2020

Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, an

1 reference

12 December 2020

Serotonin Syndrome after Concomitant Treatment with Linezolid and Citalopram

1 reference

12 December 2020

Community acquired methicillin resistant Staphylococcsus aureus: a new threat for hospital outbreaks?

1 reference

12 December 2020

Treatment of bacterial skin and skin structure infections

1 reference

12 December 2020

In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci

1 reference

12 December 2020

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

1 reference

12 December 2020

Resistance patterns among nosocomial pathogens: trends over the past few years

1 reference

12 December 2020

In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci

1 reference

12 December 2020

Effect of Linezolid versus Vancomycin on Length of Hospital Stay in Patients with Complicated Skin and Soft Tissue Infections Caused by Known or Suspected Methicillin-Resistant Staphylococci: Results from a Randomized Clinical Trial

1 reference

12 December 2020

Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance: clinical significance and treatment options

1 reference

12 December 2020

In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests

1 reference

12 December 2020

First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital

1 reference

12 December 2020

Treatment options for vancomycin-resistant enterococcal infections

1 reference

12 December 2020

Novel antibacterial agents for the treatment of serious Gram-positive infections

1 reference

12 December 2020

Arthralgias and myalgias related to quinupristin-dalfopristin administration

1 reference

12 December 2020

Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions

1 reference

12 December 2020

Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study

1 reference

12 December 2020

Multicenter, randomized study comparing levofloxacin and ciprofloxacin for uncomplicated skin and skin structure infections.

1 reference

12 December 2020

The in-vitro activity of linezolid (U-100766) and tentative breakpoints

1 reference

12 December 2020

Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin

1 reference

12 December 2020

Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infect

1 reference

12 December 2020

Linezolid: the first oxazolidinone antimicrobial

1 reference

12 December 2020

Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures

1 reference

12 December 2020

Susceptibility testing with linezolid by different methods, in relation to published 'general breakpoints'.

1 reference

12 December 2020

Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002.

1 reference

12 December 2020

Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program

1 reference

12 December 2020

Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus

1 reference

12 December 2020

Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections

1 reference

12 December 2020

Risk factors for arthralgias or myalgias associated with quinupristin-dalfopristin therapy

1 reference

12 December 2020

In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.

1 reference

12 December 2020

RP 59500: a proposed mechanism for its bactericidal activity

1 reference

12 December 2020

Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid

1 reference

12 December 2020

In vitro activity of linezolid and eperezolid against anaerobic bacteria

1 reference

12 December 2020

Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.

1 reference

12 December 2020

Two new treatment options for infections due to drug-resistant gram-positive cocci.

1 reference

12 December 2020

Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates.

1 reference

12 December 2020

Linezolid-induced lactic acidosis

1 reference

12 December 2020

Linezolid resistance in a clinical isolate of Staphylococcus aureus

1 reference

12 December 2020

Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program

1 reference

12 December 2020

Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococci

1 reference

12 December 2020

Characterisation of methicillin-resistant Staphylococcus aureus with reduced susceptibility to teicoplanin in Eastern France

1 reference

12 December 2020

[Regulation mechanism of glycopeptide resistance expression]

1 reference

12 December 2020

Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid

1 reference

12 December 2020

Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients

1 reference

12 December 2020

In vitro evaluation of BI 397, a novel glycopeptide antimicrobial agent

1 reference

12 December 2020

Moxifloxacin in uncomplicated skin and skin structure infections

1 reference

12 December 2020

10.2165/00003495-200464150-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference